At Oncopharm we are committed to delivering products of the highest quality. We believe that it is this commitment to excellence that sets us apart and allows us to deliver exceptional value to our patients and healthcare professionals.

Accordingly, we are thrilled to announce The Exciting News! Relaunching the well-known brand Valcyte® in the Egyptian market, after marketing authorization transfer from Roche to Cheplapharm Arzneimittel GmbH, through worldwide acquisition for the product, that’s definitely will help our physicians in the management of many cases who are susceptible to, or already suffering from cytomegalovirus.

Oncopharm Egypt was able to provide product of Fluorescein to the Egyptian Ministry of Health in cooperation with its partner, French company SERB.

Fluorescein injectable

Indication: diagnostic of age related macular degeneration

Strength: Fluorescein 10% Injectable solution.

Back size: box 10 ampoules

Made in France

For more details and inquires please contact us